SCHEMBL2170908

SCHEMBL2170908

O=C(Cl)Oc1ccco1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7024452 0.82 MMP1 (0.53)
SCHEMBL16196732 0.82 MMP1 (0.53)
SCHEMBL5166336 0.80
SCHEMBL1039374 0.80
SCHEMBL28045868 0.80
SCHEMBL7524679 0.78 MMP1 (0.50)
Water SCHEMBL14563848 0.78 MMP1 (0.50)
SCHEMBL28778171 0.78 MMP1 (0.54)
SCHEMBL6990198 0.78
SCHEMBL1884481 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013135235-A1 PROCESS FOR PRODUCING AND USING A GEL SYSTEM FOR OILFIELD AND GASFIELD APPLICATIONS, SUCH AS FRACKING AND WELL CLEANING, AND GEL SYSTEM PRODUCED BY THIS PROCESS AME Trade & Development GmbH (DE) 2013-09-19 WO claimed
EP-0146642-B1 PROCESS FOR THE PREPARATION OF 4-AMINO-6,7-DIMETHOXY-2-(4-(FUROYL-2)-PIPERAZIN-1-YL)-QUINAZOLINE AND ITS PHYSIOLOGICALLY ACCEPTABLE SALT LUDWIG HEUMANN &amp; CO GMBH (DE) 1988-01-20 EP claimed
EP-0146642-A1 Process for the preparation of 4-amino-6,7-dimethoxy-2-(4-(furoyl-2)-piperazin-1-yl)-quinazoline and its physiologically acceptable salt LUDWIG HEUMANN &amp; CO GMBH (DE) 1985-07-03 EP claimed
CN-118440039-A Synthesis method of carbofuran marked by stable isotope 上海化工研究院有限公司 2024-08-06 CN disclosed
EP-2346827-B1 PYRIDINE DERIVATIVES AS VEGFR-2 RECEPTOR AND PROTEIN TYROSINE KINASE INHIBITORS LEO PHARMA AS (DK) 2013-11-13 EP disclosed
US-8350026-B2 VEGF-2 receptor and protein tyrosine kinase inhibitors and pharmaceutical use thereof LEO PHARMA A/S (DK) 2013-01-08 US disclosed
US-20110190282-A1 NOVEL VEGF-2 RECEPTOR AND PROTEIN TYROSINE KINASE INHIBITORS AND PHARMACEUTICAL USE THEREOF LEO PHARMA A/S (DK) 2011-08-04 US disclosed
EP-2346827-A1 PYRIDINE DERIVATIVES AS VEGFR-2 RECEPTOR AND PROTEIN TYROSINE KINASE INHIBITORS LEO PHARMA A/S (DK) 2011-07-27 EP disclosed
EP-1765816-B1 SUBSTITUTED 1-PROPIOLYLPIPERAZINES HAVING AN AFFINITY FOR THE MGLUR5 RECEPTOR IN ORDER TO TREAT PAINFUL CONDITIONS GRUENENTHAL GMBH (DE) 2010-03-10 EP disclosed
WO-2010022725-A1 PYRIDINE DERIVATIVES AS VEGFR-2 RECEPTOR AND PROTEIN TYROSINE KINASE INHIBITORS LEO PHARMA A/S (DK) 2010-03-04 WO disclosed
EP-1551830-B1 HETEROCYCLICALLY SUBSTITUTED INDOLINONES AND THEIR USE AS RECEPTOR TYROSINE KINASE INHIBATORS BOEHRINGER INGELHEIM PHARMA (DE) 2009-04-08 EP disclosed
EP-0013361-A2 Substituted N-halogenomethyl anilides, process for their preparation and use BASF Aktiengesellschaft (DE) 1980-07-23 EP disclosed
EP-0013360-A2 N-substituted carboxylic acid anilides, process for their preparation as well as their use as fungicides BASF Aktiengesellschaft (DE) 1980-07-23 EP disclosed
EP-0012428-A1 Substituted cyanamides, process for their preparation and their use as fungicides BASF Aktiengesellschaft (DE) 1980-06-25 EP disclosed
EP-0011282-A1 Thienylbenzoic-acid derivatives, process for their production, and pharmaceutical preparations containing these compounds HOECHST AKTIENGESELLSCHAFT (DE) 1980-05-28 EP disclosed
EP-0010673-A2 Substituted N-propargyl anilines, process for their preparation and their use as fungicides BAYER AG (DE) 1980-05-14 EP disclosed
EP-0007643-A1 Oxadiazolotriazine derivatives F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1980-02-06 EP disclosed
EP-0004332-A1 Isoquinolines, process for their preparation, and pharmaceutical preparations containing them HOECHST AKTIENGESELLSCHAFT (DE) 1979-10-03 EP disclosed
US-4148895-A HYPOTENSIVE, ANTIARRHYMIA AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 1979-04-10 US disclosed
US-4100165-A Imidazo [2,1-a]isoquinolines SANDOZ, INC. (US) 1978-07-11 US disclosed